7 months ago
SLNO
AnalystsKristen KluskaKristen Kluska's Stock Forecasts
AnalystsKristen Kluska
Sectors:
Analyst Ranking
Top 3%
#93 out of 4555 analysts
Average Return
+39.51%
Win Rate
36%39 out of 109
Risk vs Reward
Poor
Good
Kristen Kluska's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocugen IncOCGN | +2,480.06% | $0.36 | $9.19 | 2020-10-08 - 2021-05-07 | Strong Buy |
Celldex Therapeutics IncCLDX | +808.47% | $3.07 | $27.89 | 2020-02-20 - 2021-02-19 | Strong Buy |
Soleno Therapeutics IncSLNO | +666.87% | $4.89 | $37.50 | 2023-08-30 - 2024-04-19 | Strong Buy |
Soleno Therapeutics IncSLNO | +666.87% | $4.89 | $37.50 | 2023-07-10 - 2024-04-19 | Strong Buy |
Taysha Gene Therapies IncTSHA | +296.41% | $0.72 | $2.87 | 2023-03-29 - 2024-03-28 | Strong Buy |
Kristen Kluska Analyst Color
Get additional color on Kristen Kluska's coverage of popular stocks
8 months ago
TSHA
10 months ago
IRON
a year ago
CBAY
a year ago
ETNB
a year ago
ETNB
a year ago
CBAY
a year ago
ABEO
Kristen Kluska's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Taysha Gene Therapies IncTSHA | 9 | Strong Buy | $7.00 | +208.37% | Reiterates | 19 hours ago |
Ptc Therapeutics IncPTCT | 10 | Strong Buy | $45.00 | +77.73% | Reiterates | 8 days ago |
89bio IncETNB | 7 | Strong Buy | $29.00 | +219.38% | Reiterates | 15 days ago |
Ultragenyx Pharmaceutical IncRARE | 6 | Strong Buy | $107.00 | +152.54% | Reiterates | 15 days ago |
Humacyte IncHUMA | 5 | Strong Buy | $7.00 | +89.19% | Reiterates | 19 days ago |
Actinium Pharmaceuticals IncATNM | 2 | Strong Buy | $21.00 | +206.57% | Reiterates | 19 days ago |
Mereo Biopharma Group PLCMREO | 4 | Strong Buy | $7.00 | +165.15% | Reiterates | 23 days ago |
Celldex Therapeutics IncCLDX | 7 | Strong Buy | $67.00 | +76.41% | Reiterates | a month ago |
Rigel Pharmaceuticals IncRIGL | 2 | Hold | $3.00 | +177.78% | Maintains | a month ago |
Adma Biologics IncADMA | 4 | Strong Buy | $8.00 | +27.59% | Maintains | 2 months ago |
Amicus Therapeutics IncFOLD | 3 | Strong Buy | $22.00 | +107.35% | Reiterates | 2 months ago |
Sarepta Therapeutics IncSRPT | 8 | Hold | $128.00 | +10.71% | Reiterates | 2 months ago |
Cymabay Therapeutics IncCBAY | 6 | Hold | $32.50 | +0.06% | Downgrades | 2 months ago |
Lineage Cell Therapeutics IncLCTX | 3 | Strong Buy | $6.00 | +421.74% | Reiterates | 2 months ago |
Capricor Therapeutics IncCAPR | 1 | Strong Buy | $8.00 | +59.68% | Initiates Coverage On | 3 months ago |
Uniqure NvQURE | 2 | Strong Buy | $21.00 | +349.68% | Reiterates | 4 months ago |
Disc Medicine IncIRON | 3 | Strong Buy | $85.00 | +196.27% | Reiterates | 4 months ago |
Soleno Therapeutics IncSLNO | 3 | Strong Buy | $35.00 | -6.67% | Maintains | 7 months ago |
Outlook Therapeutics IncOTLK | 2 | Hold | $20.00 | +144.80% | Downgrades | 8 months ago |
Alpha Tau Medical LtdDRTS | 2 | Strong Buy | $23.00 | +798.44% | Reiterates | 8 months ago |
Mustang Bio IncMBIO | 1 | Strong Buy | $18.00 | +5,163.16% | Reiterates | 8 months ago |
Abeona Therapeutics IncABEO | 4 | Strong Buy | $38.00 | +401.98% | Reiterates | 8 months ago |
Ocuphire Pharma IncOCUP | 3 | Strong Buy | $17.00 | +927.19% | Reiterates | 8 months ago |
Durect CorpDRRX | 2 | Strong Buy | $41.00 | +4,607.23% | Maintains | 8 months ago |
X4 Pharmaceuticals IncXFOR | 2 | Strong Buy | $3.00 | N/A | Maintains | a year ago |
Galecto IncGLTO | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Ibio IncIBIO | 3 | Hold | $85.00 | N/A | Downgrades | 2 years ago |
Sio Gene Therapies IncSIOX | 1 | Hold | $0.80 | N/A | Downgrades | 2 years ago |
Hepion Pharmaceuticals IncHEPA | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 2 years ago |
Eterna Therapeutics IncERNA | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 2 years ago |
Evelo Biosciences IncEVLO | 1 | Strong Buy | $560.00 | N/A | Initiates Coverage On | 3 years ago |
Chemomab Therapeutics LtdCMMB | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Ocugen IncOCGN | 3 | Hold | $11.00 | N/A | Downgrades | 3 years ago |
Marker Therapeutics IncMRKR | 2 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 3 years ago |
Evogene LtdEVGN | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Applied Genetic Technologies CorpAGTC | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 4 years ago |
Taiwan Liposome Company LtdTLC | 2 | Strong Buy | $10.00 | N/A | Reiterates | 4 years ago |
Galmed Pharmaceuticals LtdGLMD | 2 | Strong Buy | $210.00 | N/A | Assumes | 4 years ago |
Biomx IncPHGE | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.